Expanded indication from adults to pediatric patients 1 to < 17 years of age. Children < 1 year must not receive candesartan. Administering drugs that act directly on the renin-angiotensin system can have effects on the development of immature kidneys Children with glomerular filtration rate < 30ml/min/1.73m2 should not receive candesartan. In clinical trials, 4 of 233 children experienced worsening renal disease Information on preparation of an oral suspension, dosing and administration, adverse events, pharmacokinetics, and clinical trials
|